Publications
44
Citations
1,276
Est. group size
—
Recurring co-author estimate
Active years
16
Publishing since 2011
Typically publishes in teams of ~35 · 0% small-team papers (≤3 authors) · across 14 venues
- Newborn screening reduces survival disparities in SCID after stem cell transplant: A PIDTC report
Journal of Human Immunity · 2026
- Impact of Post-Consolidation MIBG (Curie) Scores on Outcomes Following Autologous Transplantation in High-Risk Neuroblastoma
Transplantation and Cellular Therapy · 2025
- Outcomes following matched sibling donor transplantation for severe combined immunodeficiency: a report from the PIDTC
Blood Advances · 2025
- Neurodevelopmental outcomes following hematopoietic cell transplantation for patients with severe combined immunodeficiency (SCID): A PIDTC study
Journal of Human Immunity · 2025
- Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment
Nature Communications · 2024
- Outcomes Following Matched Sibling Donor Transplant for Severe Combined Immunodeficiency: A Report from the Pidtc
Transplantation and Cellular Therapy · 2024
- Nephrotoxicity of Intravenous Ganciclovir in Pediatric Hematopoietic Cell Transplant Recipients
The Pediatric Infectious Disease Journal · 2024
- Incidence of Restrictive Lung Disease Following Autologous Stem Cell Transplantation for High Risk Lymphoma
Transplantation and Cellular Therapy · 2024
- Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium
The Lancet · 2023
- Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study
Journal of Allergy and Clinical Immunology · 2023
- Skeletal Biology and Late Effects Following Allogeneic Transplantation for Pediatric Hematologic Malignancy: A Ptctc and CIBMTR Multicenter Study
Transplantation and Cellular Therapy · 2023
- Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC
Blood · 2022
- Chronic Kidney Disease Is Common in Survivors of Pediatric Allogeneic Hematopoietic Cell Transplantation: A Pediatric Transplantation and Cellular Therapy Consortium Study
Transplantation and Cellular Therapy · 2022
- A Primary Immune Deficiency Treatment Consortium (PIDTC) Study of Chronic and Late Onset Medical Complications after Initial Hematopoietic Cell Transplantation (HCT) for Severe Combined Immunodeficiency Disease (SCID)
Transplantation and Cellular Therapy · 2022
- Outcomes after Hematopoietic Cell Transplant and Gene Therapy for Adenosine Deaminase (ADA) Severe Combined Immune Deficiency: A Combined Analysis from the Primary Immune Deficiency Treatment Consortium (PIDTC) 6901 and 6902 Studies
Transplantation and Cellular Therapy · 2022
- Transplantation and Cellular Therapy×9
- Journal of Clinical Immunology×4
- Blood×3
- Blood Advances×3
- Journal of Allergy and Clinical Immunology×2
- Rolla Abu‐Arja
Medicine · The Ohio State University
- Mark Vander Lugt
Medicine · University of Michigan
- Feng‐Rong Wang
Medicine · University of Michigan
- Attaphol Pawarode
Medicine · University of Michigan
- Ayman Saad
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile